Eagle Strategies’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14,052
Closed -$340K – 277
2026
Q2
$340K Sell
14,052
-594
-4% -$14.4K 0.03% 223
2026
Q1
$355K Buy
14,646
+73
+0.5% +$1.77K 0.04% 207
2025
Q4
$354K Buy
14,573
+149
+1% +$3.62K 0.05% 201
2025
Q3
$351K Buy
14,424
+1,345
+10% +$32.6K 0.05% 192
2025
Q2
$317K Buy
13,079
+97
+0.7% +$2.34K 0.05% 187
2025
Q1
$314K Buy
12,982
+4,293
+49% +$103K 0.05% 173
2024
Q4
$208K Buy
+8,689
New +$209K 0.04% 211

Other funds holding IBDS

Eagle Strategies's IBDS Position: Q3 2026 in Review

Eagle Strategies sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q3 2026, closing a stake of 14,052 shares — an estimated $340K sold.

Eagle Strategies first reported a position in IBDS in Q4 2024 and held it in 7 quarters. The position peaked at $355K in Q1 2026. 244 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

  • Eagle Strategies reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q3 2026 after selling out during the quarter.
  • Eagle Strategies sold 14,052 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $340K.
  • Eagle Strategies first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and held it in 7 quarters.
  • Eagle Strategies's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $355K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Eagle Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.